"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."
This is HCP only content
Terumo provides a wide choice of products in Interventional Oncology for the treatment of HCC, an aggressive liver malignancy that is the 6th leading cancer in the world by incidence and often occurs in the setting of chronic liver disease and cirrhosis.Find out more about how Terumo can support you in the treatment of HCC.
For Very early stage (0) and Early stage (A) HCC, Terumo offers ablation for curative treatment.
(BCLC; HCC Guidelines 2017)
Find out more about BCLC: http://www.bclc.cat/
For Intermediate stage (B), Advanced stage (C), Terumo offers chemoembalisation
(BCLC; HCC Guidelines 2017)
1 and radioembolization for palliative treatment.
Find out more about our wide choice of products that can support you in the treatment of HCC.
Giammaria Fiorentini, Donatella Sarti, Riccardo Carandina, Luca Mulazzani, Cinzia Mincarelli, Roberto Candelari, Renato Argirò, Caterina Fiorentini & Camillo Aliberti
Aliberti et al Institute for the Research and Treatment of Cancer, Padova, Italy
Hirotaka Arai et al Gunma University Graduate School of Medicine, Maebashi, Japan
Nuno Vasco Costa, MD
55 years old male with alcoholic/hepatitis C virus related cirrhosis (abstinent in the last 10 years) and elevated serum liver enzymes (ALT, AST, ALP, GGT) with a Child-Pugh score of 6 points (A).
67 years old male with alcoholic related cirrhosis (abstinent in the last 2 years) and negative HBs antigen and anti-HCV antibody. An elevated level of serum liver enzymes...
Giulio Eugenio Vallati MD
A 67-years-old man with no history of liver disease presented with 4 months of abdominal pain and weight loss. Abdominal CT showed a large hepatic lesion in the left lobe...
An 80-years-old man with history of cirrhosis (HCV+) affected by progressive weight loss and high AFP level. Abdominal CT showed a massive hepatic lesion in the right lobe...
Illario Tancredi, MD; Gontran Verset, MD
A large hepatocellular carcinoma (HCC) in the right liver lobe was diagnosed in a 66-year old patient affected by a Child A alcoholic cirrhosis. Due to the large size of the lesion a radioembolization (SIRT) was performed. But disease ...
Gontran Verset, MD; Illario, Tancredi, MD
A single 35 mm hepatocellular carcinoma (HCC) located in hepatic segment VI was diagnosed in a Child A cirrhotic patient. This 57 years-old patient was infected by...
Prof. Dr. Ralf-Thorsten Hoffmann (IR) and Dr. Klaus Zoephel (NM)
A 77-year-old male patient with a history of hepatocellular carcinoma (HCC) was first diagnosed with large HCC...
Roberto Chiavaroli MD
CF, 86-year-old man with HBV infection and liver cirrhosis (CHILD A5, MELD score 7- oesophageal varices Fo) with unifocal HCC 26 mm in size in the right lobe (VIII liver segment) detected by contrast...
Dr. Pablo Navarro Vergara
Man 55 years old with cirrhosis and HCV. Patient with previous right hepatectomy due to hepatocarcinoma (HCC) presenting a single nodular recurrence of 3 cm in the left lobe.
Woman 76 years old with cirrhosis and HCV. Presents an hepatic LOE in segment VII of 2 cm of diameter in which is performed ablation with TATO ablation device.
Hans Martin Gissler, MD
In a female patient 68 yrs. old with liver cirrhosis Child A MRI was suspicious for hepatocellular carcinoma segment VIII of 2 cm of diameter in the liver dome (Fig. 1). Tumor board transferred her to ablation.
Data on file. Terumo's products linked to BCLC Guidelines for hepatocellular carcinoma treatment as of 2017.